title: Promiscuous T-cell responses to drugs and drug-haptens.
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Fiazia S
authors.initials: FS
authors.lastname: Yaseen
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Katy
authors.initials: K
authors.lastname: Saide
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom; Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
authors.forename: Seung-Hyun
authors.initials: SH
authors.lastname: Kim
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Manal
authors.initials: M
authors.lastname: Monshi
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Arun
authors.initials: A
authors.lastname: Tailor
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Sally
authors.initials: S
authors.lastname: Wood
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Xiaoli
authors.initials: X
authors.lastname: Meng
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Rosalind
authors.initials: R
authors.lastname: Jenkins
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Lee
authors.initials: L
authors.lastname: Faulkner
authors.affiliation: Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne, United Kingdom.
authors.forename: Ann K
authors.initials: AK
authors.lastname: Daly
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: Munir
authors.initials: M
authors.lastname: Pirmohamed
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom.
authors.forename: B Kevin
authors.initials: BK
authors.lastname: Park
authors.affiliation: Department of Clinical and Molecular Pharmacology, Medical Research Council Centre for Drug Safety Science, The University of Liverpool, Liverpool, United Kingdom. Electronic address: dnes@liv.ac.uk.
authors.forename: Dean J
authors.initials: DJ
authors.lastname: Naisbitt
mesh_terms: D000658:Amoxicillin / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000938:Antigen-Presenting Cells / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D019818:Clavulanic Acid / Q000009:adverse effects; D002999:Clone Cells; D005436:Floxacillin / Q000009:adverse effects; D015870:Gene Expression; D006680:HLA Antigens / Q000235:genetics / Q000276:immunology; D006241:Haptens / Q000009:adverse effects*; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D006680:HLA Antigens; D006241:Haptens; D019818:Clavulanic Acid; D005436:Floxacillin; D000658:Amoxicillin